Antiarrhythmic drug research

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Walker, M J A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antiarrhythmic drugs; Classification; History; Mechanisms

Indexed keywords

ADENOSINE; ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DISOPYRAMIDE; LIDOCAINE; PHENYTOIN; POTASSIUM CHANNEL BLOCKING AGENT; PROCAINAMIDE; PROPRANOLOL; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

BRONCHOSPASM; DRUG CLASSIFICATION; DRUG RESEARCH; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LABORATORY; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

ANTI-ARRHYTHMIA AGENTS; BIOMEDICAL RESEARCH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; PERIODICALS; PERIODICALS AS TOPIC; PORTRAITS; SOCIETIES, SCIENTIFIC;

EID: 30444441408     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706500     Document Type: Review

References (37)

1. AU, T.L.S., COLLINS, G.A., MACLEOD, B.A. & WALKER, M.J.A. (1983). Effects of prostaglandin E2, propranolol and nitroglycerine with halothane, pethidine or pentobarbitone anaethesia on arrhythmias and other responses to ligation of a coronary artery in rats. Br. J. Pharmacol., 79, 929-937.
2. BATEY, A.J. & COKER, S.J. (2002). Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsades de pointes. Br. J. Pharmacol., 135, 1003-1012.
3. BEATCH, G.N., ABRAHAM, S., MACLEOD, B.A., YOSHIDA, N.R. & WALKER, M.J.A. (1991). Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker. Br. J. Pharmacol., 102, 13-18.
4. BILICZKI, P., VIRÁG, L., IOST, N., PAPP, J.G. & VARRÓ, A. (2002). Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve. Br. J. Pharmacol., 137, 361-368.
5. CABALLERO, R., FOURRIER, M., SCHRAM, G., DELPÓN, E., TAMARGO, J. & NATTEL, S. (2003). Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines. Br. J. Pharmacol., 138, 1475-1484.
6. CAMPBELL, T.J. & VAUGHAN WILLIAMS, E.M. (1982). Electrophysiological and other effects on rabbit hearts of CCI22277, a new steroidal antiarrhythmic drug. Br. J. Pharmacol., 76, 337-345.
7. CAST INVESTIGATORS (1989). Preliminary reports of the effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med., 321, 406-412.
8. CLEMENTS-JEWERY, H., HEARSE, D.J. & CURTIS, M.J. (2002). The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation. Br. J. Pharmacol., 137, 1089-1099.
9. CURTIS, M.J., MACLEOD, B.A. & WALKER, M.J.A. (1984). Anti-arrhythmic actions of verapamil against ischaemic arrhythmias in the rat. Br. J. Pharmacol., 83, 373-385.
10. CURTIS, M.J., MACLEOD, B.A. & WALKER, M.J. (1985). The effects of ablations in the central nervous system on arrhythmias induced by coronary occlusion in the rat. Br. J. Pharmacol., 86, 663-670.
11. CURTIS, M.J. & WALKER, M.J.A. (1986). The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat. Br. J. Pharmacol., 89, 137-147.
12. DOHADWALLA, A.N., FREEDBERG, A.S. & VAUGHAN WILLIAMS, E.M. (1969). The relevance of beta adrenoceptor blockade of ouabain-induced cardiac arrhythmias. Br. J. Pharmacol., 36, 257-267.
13. DELPON, E., VALENZUELA, C. & TAMARGO, J. (1989). Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle. Br. J. Pharmacol., 96, 970-976.
14. DESSERTENNE, F., FABIATO, A. & COUMEL, P. (1966). Un chapitre nouveau d'electro-cardiographie: Les variations progressives de l'amplitude de l'electrocardiogramme. Actual Cardiol. Angeiol. Int., 15, 241-258.
15. HONDEGHEM, L. (1987). Antiarrhythmic agents and the modulated receptor hypothesis. Circulation, 75, 514-520.
16. HOLBROOK, M. & COKER, S.J. (1991). Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetized rabbits. Br. J. Pharmacol., 103, 1973-1979.
17. KANE, K.A., PARRATT, J.R. & WILLIAMS, F.M. (1984). An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Br. J. Pharmacol., 82, 349-357.
18. LENGYEL, C., DÉZSI, L., BILICZKI, P., HORVATH, C., VIRÁG, L., IOST, N., NÉMETH, M., TÁLOSI, L., PAPP, J.G. & VARRO, A. (2004). Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk. Br. J. Pharmacol., 143, 152-158.
19. LEVY, S. & AZOULAY, S. (1994). Stories about the origin of quinquina & quinidine. J. Cardiovasc. Electrophysiol., 5, 635-636.
20. + currents. Br. J. Pharmacol., 130, 391-401.
21. MILNES, J.T., CROCIANI, O., ARCANGELI, A., HANCOX, J.C. & WITCHEL, H.J. (2003). Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652. Br. J. Pharmacol., 139, 887-898.
22. NAGY, O., HAJNAL, A., PARRATT, J.R. & VÉGH, A. (2004). Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs. Br. J. Pharmacol., 141, 549-551.
23. PALETTA, M.J., ABRAHAM, S., BEATCH, G.N. & WALKER, M.J.A. (1989). Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats. Br. J. Pharmacol., 98, 87-94.
24. REES, S.A. & CURTIS, M.J. (1993). Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts. Br. J. Pharmacol., 108, 139-145.
25. SARRAF, G., BARRETT, T.D. & WALKER, M.J.A. (2003). Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats. Br. J. Pharmacol., 139, 1389-1398.
26. SEKIYA, A. & VAUGHAN WILLIAMS, E.M. (1963). A comparison of the antifibrillatory actions and effects on intracellular cardiac potentials of pronethalol, disopyramide and quinidine. Br. J. Pharmacol., 21, 473-481.
27. SINGH, B.N. & VAUGHAN WILLIAMS, E.M. (1970a). Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle. Br. J. Pharmacol., 38, 749-757.
28. SINGH, B.N. & VAUGHAN WILLIAMS, E.M. (1970b). A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscles, of MJ 1999 and AH 3474. Br. J. Pharmacol., 39, 675-687.
29. TESCHEMACHER, A.G., SEWARD, E.P., HANCOX, J.C. & WITCHEL, H.J. (1999). Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br. J. Pharmacol., 128, 479-485.
30. TIE, H., WALKER, B.D., SINGLETON, C.B., VALENZUELA, S.M., BURSILL, J.A., WYSE, K.R., BREIT, S.N. & CAMPBELL, T.J. (2000). Inhibition of HERG potassium channels by the antimalarial agent halofantrine. Br. J. Pharmacol., 130, 1967-1975.
31. VAUGHAN WILLIAMS, E.M. (1992). Classifying antiarrhythmic actions: by facts or speculation. J. Clin. Pharmacol., 32, 964-977.
32. VAUGHAN WILLIAMS, E.M. & SZEKERES, L. (1961). A comparison of tests for antifibrillatory actions. Br. J. Pharmacol., 17, 424-432.
33. VARRÓ, A., TAKÁCS, J., NÉMETH, M., HÁLA, O., VIRÁG, L., IOST, N., BALÁTI, B., ÁGOSTON, M., VERECKEI, A., PASTOR, G., DELBRUYÈRE, M., GAUTIER, P., NISATO, D. & PAPP, J.G. (2001). Electrophysiological effects of dronedarone (SR 33589), a non-iodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br. J. Pharmacol., 133, 625-634.
34. VEGH, A., SZEKERES, L. & PARRATT, J.R. (1991). Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br. J. Pharmacol., 104, 294-295.
35. VEGH, A., PAPP, J.G., SZEKERES, L. & PARRATT, J.R. (1993). Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br. J. Pharmacol., 110, 18-19.
36. WENCKEBACH, K.F. (1923). Cinchona derivatives in the treatment of heart disorders. J. Am. Med. Assoc., 81, 472-474.
37. WYSE, K.R., YE, V. & CAMPBELL, T.J. (1993). Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea-pig myocardium. Br. J. Pharmacol., 108, 255-261.